Logo

Sigma-Aldrich Posts 13-Percent Increase in Q2 Sales Amid Rise in R&D and Profit

Jul 25, 2007
NEW YORK (GenomeWeb News) — Sigma-Aldrich yesterday said second-quarter revenue increased 13 percent as R&D spending rose 8 percent and profit climbed 13 percent.
 
Total receipts for the three months ended June 30 increased to $508 million from $449 million year over year.
 
R&D spending increased to $14.5 million from $13.4 million year over year.
 
The company said profit increased to $79.7 million from $70.3 million in the year-ago period. 
 
Sigma-Aldrich said it had around $190.1 million in cash and equivalents as of June 30.
 
Looking forward, Sigma-Aldrich said it expects sales to grow around 7 percent this year.

Breaking News
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.